glucagon-like peptide-1 (GLP-1) secretion and abrogated by the administration of Exendin(9-
نویسندگان
چکیده
ORIGINAL RESERCH ARTICLE 1 TITLE: Dual actions of a novel bifunctional compound to lower glucose in mice with diet2 induced insulin resistance 3 4 AUTHORS: 5 Katherine Chen, Alice Jih, Sarah Kavaler, William S. Lagakos, Dayoung Oh, Steve 6 Watkins, and Jane J. Kim 4 7 8 Departments of Pediatrics and Medicine, University of California at San Diego, La Jolla, 9 California, USA 10 Metabolon, Durham, North Carolina, USA 11 Rady Children’s Hospital of San Diego, California, USA 12 13 Running head: Dual actions of a novel compound to lower glucose 14 15 Corresponding Author: 16 Jane J. Kim, MD 17 9500 Gilman Drive, MC 0673 18 University of California, San Diego 19 La Jolla, CA 92093-0673 20 Tel: (858) 534-8228 21 Fax: (858) 534-6653 22 Email: [email protected] 23 Articles in PresS. Am J Physiol Endocrinol Metab (June 9, 2015). doi:10.1152/ajpendo.00045.2015
منابع مشابه
Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms.
Exogenous administration of glucagon-like peptide-1-(7-36) amide (GLP-1), an insulinotropic hormone, inhibits gastric emptying and acid secretion in humans. The role of GLP-1 as a regulator of gastric function is elusive. In gastric fistula rats, vagal afferent denervation and peripheral administration of the GLP-1 receptor antagonist exendin(9-39) amide enhanced emptying of a glucose meal, whe...
متن کاملGlucagon-like peptide-1 is a physiological incretin in rat.
Glucagon-like peptide-1 7-36 amide (GLP-1) has been postulated to be the primary hormonal mediator of the entero-insular axis but evidence has been indirect. The discovery of exendin (9-39), a GLP-1 receptor antagonist, allowed this to be further investigated. The IC50 for GLP-1 receptor binding, using RIN 5AH beta-cell membranes, was found to be 0.36 nmol/l for GLP-1 and 3.44 nmol/l for exendi...
متن کاملGlucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice.
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) potentiate glucose-stimulated insulin secretion after enteral nutrient ingestion. We compared the relative incretin and nonincretin actions of GLP-1 and GIP in +/+ and GLP-1R-/- mice using exendin(9-39) and immunopurified anti-GIP receptor antisera (GIPR Ab) to antagonize GLP-1 and GIP action, respectively. Both ...
متن کاملDose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice.
We examined the dose-related net effects of glucagon-like peptide 1 (GLP-1) on insulin secretion, insulin sensitivity, and glucose disposal as derived from the minimal model of glucose disappearance in anesthetized mice. GLP-1 dose dependently potentiated insulin secretion after glucose administration, with the half-maximal effect at 1 nmol/kg. GLP-1 also dose dependently reduced the area under...
متن کاملTruncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4.
To find mammalian analogues of exendin-4, a peptide from Helodermatidae venoms that interacts with newly discovered exendin receptors on dispersed acini from guinea pig pancreas, we examined the actions of recent additions to the vasoactive intestinal peptide/secretin/glucagon family of regulatory peptides. In every respect tested, the truncated form of glucagon-like peptide-1, GLP-1(7-36)NH2, ...
متن کاملGLP-1 Receptor Antagonist Exendin-(9-39) Elevates Fasting Blood Glucose Levels in Congenital Hyperinsulinism Owing to Inactivating Mutations in the ATP-Sensitive K+ Channel
Infants with congenital hyperinsulinism owing to inactivating mutations in the K(ATP) channel (K(ATP)HI) who are unresponsive to medical therapy will require pancreatectomy to control the hypoglycemia. In preclinical studies, we showed that the GLP-1 receptor antagonist exendin-(9-39) suppresses insulin secretion and corrects fasting hypoglycemia in SUR-1(-/-) mice. The aim of this study was to...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2015